Novel S1P1 receptor agonists – Part 5: From amino-to alkoxy-pyridines-Reference-Cited by-同舟云学术

Novel S1P1 receptor agonists – Part 5: From amino-to alkoxy-pyridines

Published:2016-06 Issue: Volume:115 Page:326-341
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Bolli Martin H.,Lescop Cyrille,Birker Magdalena,de Kanter Ruben,Hess Patrick,Kohl Christopher,Nayler Oliver,Rey Markus,Sieber Patrick,Velker Jörg,Weller Thomas,Steiner Beat

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference96 articles.

1. An update on the biology of sphingosine 1-phosphate receptors;Blaho;J. Lipid. Res.,2014

2. Sphingosine 1-phosphate (S1P): physiology and the effects of S1P receptor modulation;Hla;Neurology,2011

3. Autocrine and paracrine roles of sphingosine-1-phosphate;Alvarez;Trends Endocrinol. Metab.,2007

4. Sphingosine 1-phosphate receptors in health and disease: mechanistic insights from gene deletion studies and reverse pharmacology;Brinkmann;Pharmacol. Ther.,2007

5. Second generation S1P pathway modulators: research strategies and clinical developments;Bigaud;Biochim. Biophys. Acta,2014

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of the Clinical Candidate IDOR-1117-2520: A Potent and Selective Antagonist of CCR6 for Autoimmune Diseases;Journal of Medicinal Chemistry;2024-05-10

2. Development of a 2^nd Generation Process for 3‐Ethyl‐4‐Hydroxy‐5‐Methylbenzonitrile – A Key Building Block of S1P₁ Receptor Modulator Cenerimod – through a Non‐Classical Nitrile Formation Using Hydroxylamine‐O‐sulfonic Acid (HOSA);Helvetica Chimica Acta;2023-12

3. Phototoxicity─Medicinal Chemistry Strategies for Risk Mitigation in Drug Discovery;Journal of Medicinal Chemistry;2023-07-14

4. Multigram Synthesis of α‐ and γ‐((Hetera)cyclo)alkylpyridines through α‐Arylation of (Hetero)aliphatic Nitriles;European Journal of Organic Chemistry;2023-07-07

5. Rational Design, Synthesis, and Biological Evaluation of Novel S1PR2 Antagonists for Reversing 5-FU-Resistance in Colorectal Cancer;Journal of Medicinal Chemistry;2022-10-21